InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,212.40
(
-0.24%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.93
(
-0.09%
)
Bitcoin
63,841.25
(
-1.52%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

OakesCS

Send PM Follow Ignore
Followers 16
Posts 1503
Boards Moderated 0
Alias Born 05/03/2005

OakesCS

Re: None

Tuesday, 11/06/2007 8:22:43 AM

Tuesday, November 06, 2007 8:22:43 AM

Post# of 252279
MNTA enoxaparin denied

first i've heard about immunogenicity concern although i'm admittedly illiterate in the biotech field.

wondering what people's opinions are as to time line to address and whether premarket price level ~$6.70 reduces MNTA to 'opportunity' level for future products (if Yahoo is to be believed, cash value is about $4).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up